Robert Ginsberg
Family Medicine · Burtonsville, MDNPI 1801820964
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,351 of the $5,732 with a category attached, or 75.9%. It is spread thinly across 32 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,335 and has fallen 99.2% since, to $19 in 2024. Among family medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $28.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$1K
- Novo Nordisk$815
- AstraZeneca$626
- Lilly USA, LLC$292
- Boehringer Ingelheim$244
- plus $1K from 26 others
What the payments were for
- Consulting fees$1,20021%
- Food & beverage$4,35176%
- Education$1813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 9 | $1,360 |
| AbbVie(2 entities) | 52 | $1,174 |
| Novo Nordisk | 39 | $815 |
| AstraZeneca | 25 | $626 |
| Lilly USA, LLC | 12 | $292 |
| Boehringer Ingelheim | 5 | $244 |
| Pfizer | 10 | $192 |
| Astellas Pharma US Inc | 1 | $99 |
| Eisai Inc. | 5 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $87 |
| Currax Pharmaceuticals LLC | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $82 |
| Penumbra, Inc. | 2 | $73 |
| Johnson & Johnson | 3 | $62 |
| Merck | 4 | $59 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Exact Sciences | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Gilead | 1 | $20 |
| GSK | 1 | $20 |
| Novartis | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Amgen | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,732 in reported general payments places this provider in the 90th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lubiprostone | 12 | $2,848 |
| Temazepam | 12 | $782 |
| Rosuvastatin Calcium | 23 | $505 |
| Telmisartan | 16 | $256 |
| Tamsulosin Hcl | 16 | $237 |
| Atorvastatin Calcium | 12 | $163 |
| Levothyroxine Sodium | 15 | $131 |
| ClopidogrelClopidogrel Bisulfate | 11 | $108 |
| Amlodipine Besylate | 13 | $87 |
| Simvastatin | 15 | $28 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Burtonsville
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
- Tramaine DavisBowie$43K
- Alkesh PatelColumbia$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.